The Genetic Blueprint: Why ARS Happens

Understanding the biology of Axenfeld-Rieger Syndrome (ARS) requires looking back to the very first weeks of life. During pregnancy, a group of specialized cells called neural crest cells must migrate to the front of the eye to form structures like the cornea, iris, and the drainage system ^[1]. In ARS, these cells do not migrate or separate properly, leaving the eye’s front structures “stuck” together or underdeveloped ^[2].

The Role of PITX2 and FOXC1

Most cases of ARS are caused by a change in one of two specific genes: PITX2 or FOXC1 ^[3]. These genes encode transcription factors, which are proteins that turn other genes “on” or “off” at specific times during development ^[4].

• PITX2: This is heavily involved in the development of the eye, teeth, and the area around the belly button ^[5][6].
• FOXC1: This is critical for the eye’s drainage system and the development of the heart and hearing ^[4][6].

When one of these genes is mutated, the “downstream” instructions for building the eye and other organs are not followed correctly ^[7].

How ARS is Inherited

ARS usually follows an autosomal dominant inheritance pattern ^[8].

• The 50% Rule: You only need one copy of the mutated gene to have the syndrome. If a parent carries the variant, there is a 50% chance they will pass it to each child ^[8].
• De Novo Mutations: Many people are the first in their family to have ARS. This is called a de novo (new) mutation, where the genetic change happens spontaneously in the egg or sperm, and the parents do not have the condition themselves ^[9].
• Variable Expressivity: Even family members with the exact same mutation can have very different symptoms. One person might have severe glaucoma, while another only has a slightly differently shaped pupil ^[6][10].

Testing and Genetic Counseling

Because ARS is a clinical diagnosis, a doctor can often “see” it during an eye exam. Genetic testing is used to support or clarify the diagnosis and guide care, but it is not the only way to know you have the condition. A complete evaluation often includes two types of tests:

1. Sequencing: This “reads” the gene letter-by-letter to find small typos ^[11].
2. Copy-Number Analysis: This checks if entire sections of the gene are missing (deletions) or extra (duplications) ^[11][12].

Working with a genetic counselor is crucial. They can explain testing options, discuss privacy and insurance considerations, and help with reproductive planning. They can also explain the difference between a definitive pathogenic variant and a variant of uncertain significance (VUS), which means a change was found but it is not yet known if it causes disease.

Why a Test Might Be Negative

Depending on the testing method, about 30% to 60% of people who clearly have ARS will receive a “negative” genetic test result for PITX2 and FOXC1 ^[11][13]. This does not mean you don’t have the syndrome. There are several reasons why this happens:

• Non-coding regions: Standard tests like exome sequencing primarily look at the “coding” regions of genes. They may miss structural, mosaic, or regulatory changes in non-coding DNA that act as remote controls ^[14][15].
• Hidden Rearrangements: Sometimes the DNA is flipped or moved in a complex way that standard sequencing cannot detect ^[16].
• Undiscovered Genes: Scientists are still identifying new genes that might cause ARS or similar conditions ^[17].

If your first test is negative, your doctor may recommend exome sequencing or genome sequencing to search for these rarer causes ^[17][16]. Regardless of the test result, if you have the physical signs of ARS, you still need lifelong monitoring for glaucoma and other systemic features ^[18].

Testing the Family

When a mutation is found, doctors often recommend cascade testing for biological relatives ^[19]. This helps determine if a relative carries the same gene change, even if they have no obvious symptoms. Because some people carry the gene but have almost no visible signs (reduced penetrance), this testing is a key way to know their true risk for passing it on or developing high eye pressure later in life ^[10].